Where Does Align Technology, Inc. (ALGN) Stock Fall in the Medical Devices Field?

Thursday, September 24, 2020 11:14 AM | InvestorsObserver Analysts

Align Technology, Inc. (ALGN) is near the top in its industry group according to InvestorsObserver. ALGN gets an overall rating of 58. That means it scores higher than 58 percent of stocks. Align Technology, Inc. gets a 79 rank in the Medical Devices industry. Medical Devices is number 64 out of 148 industries.

Overall Score - 58
ALGN has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on ALGN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 58 would rank higher than 58 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Align Technology, Inc. Stock Today?

Align Technology, Inc. (ALGN) stock is trading at $307.81 as of 11:00 AM on Thursday, Sep 24, a loss of -$0.51, or -0.17% from the previous closing price of $308.32. Volume today is less active than usual. So far 196,423 shares have traded compared to average volume of 637,423 shares. The stock has traded between $297.44 and $308.17 so far today.

Click Here to get the full Stock Score Report on Align Technology, Inc. (ALGN) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Does Intuitive Surgical, Inc. (ISRG) Have What it Takes to be in Your Portfolio?

Is Tilray Inc (TLRY) the Top Pick in the Drug Manufacturers - Specialty & Generic Industry?

Should Endo International PLC (ENDP) be in Your Portfolio?

Is Kamada Ltd. (KMDA) the Top Pick in the Drug Manufacturers - Specialty & Generic Industry?

Is Thermo Fisher Scientific Inc. (TMO) Stock a Great Value?

Should Chimerix Inc (CMRX) Stock be in Your Portfolio?

Related Companies